Top compounds associated with response to LINC00094


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.07
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.057 0.08
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC -0.073 0.08
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.066 0.08
mRNA QS11 CTRPv2 pan-cancer AAC 0.13 0.08
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC 0.13 0.08
mRNA lovastatin CTRPv2 pan-cancer AAC 0.067 0.08
mRNA Bortezomib gCSI pan-cancer AAC -0.1 0.08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.08
mRNA erismodegib CTRPv2 pan-cancer AAC -0.069 0.08
Download CSV